These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Obsessive-compulsive disorder]. van Grootheest DS; van den Heuvel OA; Cath DC; van Oppen P; van Balkom AJ Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2325-9. PubMed ID: 19024062 [TBL] [Abstract][Full Text] [Related]
24. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology. Korff S; Harvey BH Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714 [TBL] [Abstract][Full Text] [Related]
25. Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo. Stein DJ; Andersen EW; Overo KF Braz J Psychiatry; 2007 Dec; 29(4):303-7. PubMed ID: 18200396 [TBL] [Abstract][Full Text] [Related]
26. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Denys D Psychiatr Clin North Am; 2006 Jun; 29(2):553-84, xi. PubMed ID: 16650723 [TBL] [Abstract][Full Text] [Related]
27. Does melatonin mediate the therapeutic effects of 5-HT reuptake inhibitors in obsessive compulsive disorder? Sandyk R Int J Neurosci; 1992; 64(1-4):221-3. PubMed ID: 1342043 [No Abstract] [Full Text] [Related]